Emerson Electric Co.(EMR)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
EMR | 83.79 B | 33.53x | 7.00% | 13.83% | $4.48 | 12.80% | 0.68 | 1.43% | $165.79 | $121.73 |
3665.TW | 418.44 B | 39.38x | 37.50% | 12.90% | $54.47 | 24.66% | 0.36 | 71.00% | $2983.85 | $937.78 |
VRT | 103.50 B | 60.41x | 24.10% | 15.09% | $4.45 | 43.94% | 0.70 | 10.00% | $379.86 | $118.57 |
AME | 53.69 B | 34.34x | 15.00% | 20.04% | $6.82 | 14.56% | 0.21 | 58.00% | $261.16 | $178.41 |
ROK | 47.66 B | 40.67x | 7.90% | 13.39% | $10.53 | 30.63% | 1.03 | 1.28% | $495.83 | $328.32 |
Peer Valuation & Performance Analysis
Peer group analysis for Emerson Electric Co. (EMR) compared to its primary competitors (including 3665.TW, VRT, AME) reveals distinct metrics. EMR trades at a valuation discount relative to its competitors, with a P/E ratio of 33.5x versus the peer average of 43.7x (representing a 23% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, EMR's revenue growth of 7.0% lags behind the peer average of 21.1%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 13.8% is comparable to the peer average of 15.4%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• EMR ranks #1 in P/E ratio, #5 in revenue growth, and #3 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $150.25 | $151.10 | $147.15 | $150.21 | 1,596,400 | -0.03% |
| 2026-09-02 | $148.01 | $150.60 | $146.35 | $148.98 | 2,885,700 | +0.66% |
| 2026-09-01 | $151.48 | $152.26 | $146.97 | $147.63 | 2,700,400 | -2.54% |
| 2026-08-31 | $153.77 | $154.49 | $152.13 | $152.44 | 2,285,400 | -0.86% |
| 2026-08-28 | $158.27 | $158.64 | $154.42 | $155.18 | 1,533,800 | -1.95% |
| 2026-08-27 | $158.60 | $158.98 | $156.55 | $157.71 | 1,710,300 | -0.56% |
| 2026-08-26 | $155.58 | $158.70 | $155.50 | $158.29 | 2,066,500 | +1.74% |
| 2026-08-25 | $159.80 | $159.82 | $154.60 | $154.96 | 3,112,000 | -3.03% |
| 2026-08-24 | $157.37 | $158.20 | $156.21 | $157.57 | 1,722,000 | +0.13% |
| 2026-08-21 | $156.45 | $157.48 | $155.08 | $157.26 | 2,081,300 | +0.52% |
| 2026-08-20 | $155.77 | $157.25 | $154.08 | $154.72 | 1,821,600 | -0.67% |
| 2026-08-19 | $159.11 | $159.70 | $157.18 | $157.60 | 1,554,700 | -0.95% |
| 2026-08-18 | $161.09 | $161.50 | $157.73 | $157.78 | 2,120,300 | -2.05% |
| 2026-08-17 | $162.99 | $164.35 | $161.55 | $162.05 | 2,054,100 | -0.58% |
| 2026-08-14 | $164.26 | $164.80 | $162.30 | $163.17 | 2,144,400 | -0.66% |
Explore More Analysis for EMR
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.